Emerald Mutual Fund Advisers Trust Travere Therapeutics, Inc. Transaction History
Emerald Mutual Fund Advisers Trust
- $1.47 Billion
- Q2 2025
A detailed history of Emerald Mutual Fund Advisers Trust transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 1,141,428 shares of TVTX stock, worth $19.9 Million. This represents 1.15% of its overall portfolio holdings.
Number of Shares
1,141,428
Previous 1,121,886
1.74%
Holding current value
$19.9 Million
Previous $20.1 Million
15.97%
% of portfolio
1.15%
Previous 1.63%
Shares
8 transactions
Others Institutions Holding TVTX
# of Institutions
242Shares Held
102MCall Options Held
1.79MPut Options Held
540K-
Armistice Capital, LLC New York, NY8.87MShares$154 Million2.42% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$133 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X07.53MShares$131 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.99MShares$104 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C34.8MShares$83.5 Million0.11% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.12B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...